| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
12,108 |
9,694 |
$534K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,276 |
7,726 |
$440K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,251 |
1,179 |
$96K |
| 99310 |
Prolong nursin fac eval 15m |
1,171 |
689 |
$15K |
| 0001A |
|
333 |
321 |
$12K |
| 0002A |
|
293 |
284 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
145 |
107 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
109 |
109 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
24 |
24 |
$2K |
| 0003A |
|
49 |
49 |
$2K |
| 0071A |
|
42 |
42 |
$2K |
| 0072A |
|
32 |
32 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
77 |
43 |
$847.86 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13 |
12 |
$724.50 |
| 0013A |
|
16 |
16 |
$640.00 |
| 90480 |
|
16 |
16 |
$560.00 |
| 90674 |
|
15 |
13 |
$292.46 |
| 0011A |
|
13 |
13 |
$220.22 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
25 |
$96.72 |
| 90672 |
|
15 |
14 |
$67.74 |
| 90686 |
|
13 |
13 |
$32.84 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46 |
46 |
$0.00 |
| 1036F |
|
45 |
43 |
$0.00 |